patients with post-thoracotomy pain
Conditions
Interventions
Contorol group(Standerd treatment group) The following treatments for 2 weeks -Codeine phsphate power 25mg, TID -Acetaminophen 400mg, TID
Study treatment group(Tramadol group) -Tramadol hydrochlor
Sponsors
Gifu University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 1.Lung cancer patients who recerived thoracotomy 2.Patients who complain of 3.Patients who are 20 years old or older 4.Patients who agreed to participate in the study and signed informed consent form
Exclusion criteria
Exclusion criteria: 1.Patients with severe renal impairment 2.Patients with pneumothorax or who received mediastinotomy 3.Patients with interstitial pneumonia 4.Patients with history of a previous ipsilateral thoracotomy 5.Patients who used opioids,gabapentine, and/or pregabalin before surgery 6.Other patients considered to be ineligible to participate in the study by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS(Visual Analogue Scale) at 2week (at rest, at coughing) | — |
Secondary
| Measure | Time frame |
|---|---|
| 1)VAS at day 0 to 7, 4week and 3month (pain at rest or at coughing) 2)VAS before breakfast, lunch and dinner at day 2 and 3(pain at rest or at coughing) 3)SF-MPQ 4)EQ-MPQ 5)Sleep disorder score 6)incidence of adverse reaactions 7)number of rescure medication use 8)scleening tool of neuropathic pain at month 3 | — |
Countries
Japan
Contacts
Public ContactNoritaka Yoshimura
Gifu University Graduate School of Medicine Department of Anesthesiology and Pain Medicine
Outcome results
None listed